Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: AMC 075 Principal Investigator: Ratner, Lee
Title: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma
Phase: I/II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
This study is being conducted because scientists think that adding vorinostat therapy may enhance the effectiveness of standard chemotherapy plus rituximab in certain types of lymphoma, and may also have a positive effect against HIV and other viruses in our bodies which can cause lymphoma.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)